Brooklyn ImmunoTherapeutics Inc (BTX) News

Quarterly Report (10-q)

false12-312023Q10000748592P2Y6MP5Y6MP10DP10D00007485922023-01-012023-03-3100007485922023-05-1100007485922023-03...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement...

Annual Report to Security Holders (ars)

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION...

Proxy Statement (definitive) (def 14a)

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 14A INFORMATIONProxy Statement Pursuant to...

Current Report Filing (8-k)

false0000748592NASDAQ00007485922023-05-022023-05-02 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

TABLE OF CONTENTSFiled pursuant to Rule 424(b)(3) Registration No. 333-271279PROSPECTUSEterna Therapeutics Inc.2,930,237 Shares of Common...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 14A INFORMATIONProxy Statement Pursuant to...

Current Report Filing (8-k)

false0000748592NASDAQ00007485922023-04-052023-04-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington...

Amended Statement of Ownership (sc 13g/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     SCHEDULE 13G Under the...

Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

TABLE OF CONTENTSFiled Pursuant to Rule 424(b)(3)Registration No. 333-264585PROSPECTUSEterna Therapeutics Inc. 685,714 Shares of Common...

Initial Statement of Beneficial Ownership (3)

FORM 3          UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

false000074859200007485922023-01-202023-01-20 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

false0000748592MANASDAQ00007485922023-01-092023-01-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...